Islet Amyloid Polypeptide clinical trials
How each study uses Islet Amyloid Polypeptide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Islet Amyloid Polypeptide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Amylin
- 2
By phase
A phase 1/2 study counts in both.
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Danish Headache Center (2) · University Hospital, Gentofte, Copenhagen (1)
Often tested with
Tested in the same studies.
Pancreatic Polypeptide (1)
Studies
Open first, then newest update. How each study uses Islet Amyloid Polypeptide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy HumansRecruitingNot applicableUniversity Hospital, Gentofte, CopenhagenNCT07506369Written as Amylin (Pramlintide)
- Amylin-Induced Migraine Attacks Without AuraNot yet recruitingNot applicableDanish Headache CenterNCT07340788Written as Amylin
- Hypersensitivity to Amylin in Post-Traumatic HeadacheNot yet recruitingNot applicableDanish Headache CenterNCT07340775Written as Amylin
Codes
What other systems call Islet Amyloid Polypeptide · ClinicalTrials.gg INT008924
- MeSH (NLM) D058228Islet Amyloid PolypeptideOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D058228 | Islet Amyloid Polypeptide | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.